FDA UNTITLED_LETTER - Wedgewood Connect, LLC - November 09, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Wedgewood Connect, LLC

Record Details

This UNTITLED LETTER record concerns Wedgewood Connect, LLC, with an inspection on November 9, 2023, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Company: Wedgewood Connect, LLC
Inspection Date: November 9, 2023
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations I
People: Lance M. De Souza (Director - Compliance Branch)
Marcy Bliss
Steven E. Porter (Program Division Director)
Andrew K. Haack (Compliance Officer)

Open in Dashboard

ID · c7b71d6a-971e-480f-9e52-95939c6a80af

Violation Codes10

21 U.S.C. 353b21 U.S.C. 353b(a)(10)21 CFR 21021 CFR 201.11521 CFR 211.113(b)21 CFR 211.165(d)21 CFR 211.19221 CFR 211.42(c)(10)(iv)21 CFR 211.42(c)(10)(v)21 CFR 211.22(a)

Full citation text and observation details available on the Dashboard.